基础医学与临床 ›› 2016, Vol. 36 ›› Issue (7): 1026-1029.

• 短篇综述 • 上一篇    下一篇

PAX6基因在肿瘤中的研究进展

任佳琦1,袁宁潞1,闫冬1,田谱1,徐苗2   

  1. 1. 四川大学华西临床医学院
    2. 四川大学华西医院
  • 收稿日期:2016-05-04 修回日期:2016-05-16 出版日期:2016-07-05 发布日期:2016-06-22
  • 通讯作者: 徐苗 E-mail:miao6362@163.com
  • 基金资助:
    高等学校博士学科点专项科研基金

Researh advances of PAX6 gene in cancer

  • Received:2016-05-04 Revised:2016-05-16 Online:2016-07-05 Published:2016-06-22

摘要: PAX6是PAX基因家族重要成员,在进化上高度保守,编码的转录因子在转录调控过程中发挥重要作用,参与胚胎发育、肿瘤发生等多种重要生物学过程。研究发现PAX6在肺癌、乳腺癌、胰腺癌、前列腺癌和胶质瘤的发生发展中扮演重要角色,它能调控cdc2、cyclin D1、p21、p27、MMP-2/9和VEGFA等靶基因表达,调控细胞增殖、凋亡、周期、侵袭和血管生成,其调控和功能的异常与肿瘤的发生发展密切相关。PAX6有望成为肿瘤治疗的潜在靶点。

关键词: Pax6, 肿瘤, 综述

Abstract: PAX6, which is a PAX gene family member, is a highly conserved transcriptional regulator, plays vital roles in multiple biological processes such as embryonic development and tumorigenesis. It was reported that PAX6 regulates target gene expression including cdc2, cyclin D1, p21, p27, MMP-2 and VEGFA, controls cell growth, apoptosis, cell cycle, invasion and angiogenesis, affects tumorigenesis and progression of various types of cancer. PAX6 will be a potential target in the field of cancer therapy.

Key words: PAX6 gene, cancer, review